Interaction in vivo between tumor cells and phagocytes.
Notario
A
A
Department of Internal Medicine and Medical Therapy, University of Pavia, Italy.
Mazzucchelli
I
I
Fossati
G
G
Baldi
A
A
Rolandi
M L
ML
D015703:Antigens, CD / Q000097:blood; D002634:Chemotaxis, Leukocyte; D015179:Colorectal Neoplasms / Q000097:blood* / Q000276:immunology; D016207:Cytokines / Q000097:blood; D066246:ErbB Receptors / Q000097:blood; D006098:Granulocytes / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood* / Q000276:immunology; D009000:Monocytes / Q000276:immunology / Q000502:physiology*; D009504:Neutrophils / Q000276:immunology / Q000502:physiology*; D010587:Phagocytosis; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000097:blood; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood; D017472:Receptors, Interleukin-1 / Q000097:blood; D019948:Receptors, Interleukin-4 / Q000097:blood; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood
D015703:Antigens, CD; D016207:Cytokines; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D016187:Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; D017472:Receptors, Interleukin-1; D019948:Receptors, Interleukin-4; D018124:Receptors, Tumor Necrosis Factor; D066246:ErbB Receptors